FREQUENCY AND SEVERITY OF STEATOSIS IN PATIENTS WITH CHRONIC HEPATITIS-C
AbstractBackground: Hepatitis-C viral infection is a global health problem. It has been estimated that approximately 170 million individuals are infected with hepatitis-C virus. Hepatic steatosis is a frequent histological feature in patients with chronic hepatitis-C infection. Histological examinations show that up to 50% of these patients have variable degrees of hepatic steatosis, even in the absence of other possible steatogenic factors like alcohol, drugs or metabolic syndromes. The objective of this study was to determine the frequency and severity of steatosis in patients with Chronic Hepatitis-C. Methods: This cross sectional study was carried out from 1st January 2010 to 1st July 2010 at the department of Gastroenterology PIMS, Islamabad. A total of 127 patients of chronic hepatitis-C were enrolled in the study after taking informed written consent. Frequency and severity (mild, moderate and severe) of steatosis was assessed on the basis of liver biopsy. Results: A total of 127 patients were included in the study. Mean age of the patients was 36.24 years. Out of 127 patients, 48(38%) were male and 79(62%) were female. Steatosis was present in 50(39%) patients with chronic hepatitis-C infection. whereas steatosis was absent in 77(61%) patients. Conclusion: The presence of steatosis on liver biopsy in patients with chronic hepatitis-C is common (39% patients) and female patients had slightly more severe degree of steatosis as compared to male patients.Keywords: Chronic hepatitis-C, Steatosis, Frequency, Severity
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis-C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013;57(4):1333–42.
Raja NS, Janjua KA. Epidemiology of hepatitis-C virus infection in Pakistan. J Microbiol Immunol Infect. 2008;41(1):4–8.
Khokhar N. Spectrum of chronic liver disease in a tertiary care hospital. J Pak Med Assoc. 2002; 52(2):56–8.
Umar M, Bushra HT, Shuaib A. Spectrum of chronic liver disease due to hepatitis-C virus infection. J Coll Physicians Surg Pak 2000;10:380–3.
Khokhar N. Management of chronic hepatitis-C. J Rawal Med Coll 2001;5(2):104–6.
Jármay K, Karácsony G, Ozsvár Z, Nagy I, Lonovics J, Schaff Z. Assessment of histological features in chronic hepatitis-C. Hepatogastroenterology 2002;49(43):239–43.
Tuncer G, Erden E, Elhan AH. Morphological characteristics of chronic hepatitis-C: a comparative study on Turkish patients. Acta Gastroenterol Belg 2002;65(3):146–9.
Westin J, Nordlinder H, Lagging M, Norkrans G, Wejstal R. Steatosis accelerates fibrosis development over time in hepatitis-C virus genotype 3 infected patients. J Hepatol 2002;37(6):837–42.
Monto A. Hepatitis-C and steatosis. Semi Gastrointest Dis 2002;13(1):40–6.
Hui JM, Kench J, Farrell GC, Lin R, Samarasinghe D, Liddle C, et al. Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis-C infection. J Gastroenterol Hpatol 2002;17(8): 873–81.
Yoon EJ, Hu KQ. Hepatitis-C virus (HCV) infection and hepatic steatosis. Int J Med Sci 2006;3(2):53–6.
Umar M, Bushra HT, Shuaib A. Spectrum of chronic liver disease due to hepatitis-C virus infection. J Coll Physicians Surg Pak 2000;10(10):380–3.
Khokhar N. Spectrum of chronic liver disease in a tertiary care hospital. J Pak Med Assoc 2002;52(2):56–8.
Bach N, Thung SN, Schaffner F: The histological features of chronic hepatitis-C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992;15(4):572–7.
Fischer HP, Willsch E, Bierhoff E, Pfeifer U: Histopathologic findings in chronic hepatitis-C. J Hepatol 1996;24(2):35–42.
Goodman ZD, Ishak KG: Histopathology of hepatitis-C virus infection. Semin Liver Dis 1995;15(1):70–81.
Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Host- and disease- specific factors affecting steatosis in chronic hepatitis-C. J Hepatol 1998;29(2):198–206.
Matos CA, Perez RM, Pacheco MS, Figueiredo-Mendes CG, Lopes-Neto E, Oliveira EB Jr, et al. Steatosis in Chronic Hepatitis-C: Relationship to the Virus and Host Risk Factors. J Gastroenterol Hepatol 2006;21(8):1236–9.
Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis-C. Hepatology 1992;15(4):567–71.
Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, et al. Fibrosis in chronic hepatitis-C correlates significantly with body mass index and steatosis. Hepatol 1999;29(4):1215–9.
Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterol 1993;105(6):1824–32.
Khokhar N, Asif N, Khokhar OS. Hepatitis-C virus serotypes in chronic liver disease. Pak J Med Sci 2002;18:156–9.
Bacon BR, Farahvash MJ, Janney CG, Neuschwander Tetri BA. Nonalcohol steatohepatitis: an expanded clinical entity. Gastroenterol 1994;107(4):1103–9.
Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55(7):434–8.
Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Malé PJ, Mentha G, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis-C virus genotype 3. J Hepatol 2000;33(1):106–15.
Hézode C, Roudot-Thoraval F, Zafrani ES, Dhumeaux D, Pawlotsky JM. Different mechanisms of steatosis in hepatitis-C virus genotypes 1 and 3 infections. J Viral Hepat 2004;11(5):455–8.
Asselah T, Rubbia-Brandt L, Marcellin P, Negro F. Steatosis in chronic hepatitis-C: why does it really matter? Gut 2006;55(1):123–30.
Syed GH, Amako Y, Siddiqui A. Hepatitis-C virus hijacks host lipid metabolism. Trends Endocrinol Metab 2010;21(1):33–40.
Ishak K, Baptista A, Biachi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22(6):696–9.